Skip to main content

Expensify, Inc.

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

EXFY$1.72-7.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

(unaudited, in thousands)

Six Months Ended June 30,
20262025
Cash flows from operating activities:
Net loss$(6,188)$(11,957)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization4,5984,041
Reduction of operating lease right-of-use assets272279
Loss on impairment, receivables and sale or disposal of equipment720334
Stock-based compensation expense13,18814,917
Amortization of debt issuance costs8357
Deferred income taxes51(4)
Changes in assets and liabilities:
Accounts receivable, net819212
Settlement assets, net(3,321)(5,994)
Prepaid expenses1,1899,565
Other current assets6,525(2,186)
Other assets(97)(19)
Accounts payable3291,336
Accrued expenses and other liabilities(9,995)962
Operating lease liabilities(287)(281)
Settlement liabilities4784,947
Other liabilities187(169)
Net cash provided by operating activities8,55116,040
Cash flows from investing activities:
Purchase of property and equipment—(17)
Software development costs(2,491)(1,655)
Net cash used in investing activities(2,491)(1,672)
Cash flows from financing activities:
Change in customer funds, net4,251(2,319)
Principal payments of finance leases(74)(68)
Payments for debt issuance costs(114)(88)
Proceeds from common stock purchased under the Matching Plan3,2832,610
Proceeds from issuance of common stock upon exercise of stock options39117
Repurchase and retirement of common stock(8,451)(3,026)
Net cash used in financing activities(1,066)(2,774)
Net increase in cash and cash equivalents and restricted cash4,99411,594
Cash and cash equivalents and restricted cash at beginning of period104,62490,834
Cash and cash equivalents and restricted cash at end of period$109,618$102,428
Noncash investing and financing items:
Stock-based compensation capitalized as software development costs$710$775
Repurchases and retirement of common stock in accounts payable and accrued expenses$774$—

The accompanying notes are an integral part of these condensed consolidated financial statements.

Condensed Consolidated Statements of Cash Flows

(unaudited, in thousands)

Purchases of property and equipment and capitalized software in accounts payable and accrued expenses$26$31
Fair value of common stock issued to settle liability-classified restricted stock units$718$343
Reconciliation of cash and cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets:
Cash and cash equivalents$65,760$60,519
Restricted cash included in other current assets20,07421,132
Restricted cash included in settlement assets, net23,78420,777
Total cash and cash equivalents and restricted cash$109,618$102,428

The accompanying notes are an integral part of these condensed consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.